Company Theraclion

Equities

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Real-time Euronext Paris Other stock markets 06:26:16 30/04/2024 pm IST			5-day change	1st Jan Change
0.379 ^EUR	+1.07%		+5.28%	-2.32%

27/03	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows:

- sale of equipment (61.8%);

- sale of consumables (29%);

- provision of after-sales services (9.2%).

Export accounts for 99.7% of net sales.

Number of employees: 30

EUR in Million	Weight	2021	Weight	Delta
Equipment 71.5 %	37.2 %	1	71.5 %	+282.31%
Services 15.0 %	20.4 %	0	15.0 %	+46.05%
Consumables 13.5 %	42.3 %	0	13.5 %	-36.51%

EUR in Million	2020	Weight	2021	Weight	Delta
Germany, Hong Kong and China 100.0 %	1	100.0 %	1	100.0 %	+99.05%

Managers	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	01/20/01
Laurence Géricot DFI	Director of Finance/CFO	-	-
Gaylord Tallec COO	Chief Operating Officer	-	-
Jeremie Anquez CTO	Chief Tech/Sci/R&D Officer	-	-
Michel Nuta CTO	Chief Tech/Sci/R&D Officer	-	01/13/01

Members of the board	Title	Age	Since
Ari Kellen BRD	Director/Board Member	-	13/19/13
Renaud Saleur BRD	Director/Board Member	-	01/18/01
Yann Duchesne CHM	Chairman	67	24/22/24
Samuel G. Levy BRD	Director/Board Member	-	12/16/12
Mehdi El Glaoui BRD	Director/Board Member	-	22/21/22
Shawn Langer BRD	Director/Board Member	-	13/19/13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	44,263,960	31,520,939 ( 71.21 %)	22,865 ( 0.0517 %)	71.21 %

Name	Equities	%	Valuation
DNCA Finance SA 2.390 %	1,093,090	2.390 %	448 604 €
Friedland Gestion SAS 1.704 %	779,192	1.704 %	319 780 €
OFI Invest Asset Management SA 0.5727 %	261,902	0.5727 %	107 485 €
Allianz Global Investors GmbH (France) 0.001364 %	624	0.001364 %	256 €

Théraclion SA

244, avenue Pierre Brossolette

92240, Malakoff

+33 1 55 48 90 70

http://www.theraclion.fr

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERACLION	-2.32%	18.22M
THERMO FISHER SCIENTIFIC	+8.69%	220B
DANAHER CORPORATION	+6.69%	183B
INTUITIVE SURGICAL, INC.	+10.90%	133B
BOSTON SCIENTIFIC CORPORATION	+25.41%	107B
SIEMENS HEALTHINEERS AG	-1.29%	63.05B
EDWARDS LIFESCIENCES CORPORATION	+12.72%	51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	50.47B
AGILENT TECHNOLOGIES, INC.	+0.40%	40.91B
RESMED, INC.	+26.26%	31.91B

Other Advanced Medical Equipment & Technology